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Abstract 
Pathophysiology in schizophrenia has been linked to aberrant incentive salience, namely the 
dysfunctional processing of value linked to abnormal dopaminergic activity. In line with this, 
recent studies showed impaired learning of value in schizophrenia. However, how value is 
used to guide behaviour independently from learning, as in risky choice, has rarely been 
examined in this disorder. We studied value-guided choice under risk in patients with 
schizophrenia and in controls using a task requiring a choice between a certain monetary 
reward, varying trial-by-trial, and a gamble offering an equal probability of getting double 
this certain amount or nothing. We observed that patients compared to controls exhibited 
reduced sensitivity to values, implying that their choices failed to flexibly adapt to the 
specific values on offer. Moreover, the degree of this value sensitivity inversely correlated 
with aberrant salience experience, suggesting that the inability to tune choice to value may be 
a key element of aberrant salience in the illness. Our results help clarify the cognitive 
mechanisms underlying improper attribution of value in schizophrenia and may thus inform 
cognitive interventions aimed at reinstating value sensitivity in patients. 
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1. Introduction 
 
Schizophrenia is a severe mental health condition affecting approximately 1% of the general 
population worldwide and impacting on individuals, their carers and society (McGrath et al., 
2008). It is characterized by a complex clinical profile comprising cognitive deficits, 
motivational impairments and aberrant perceptual and thought processes. However, its 
mechanisms remain unknown. One of the most influential accounts of schizophrenia posits 
that aberrant incentive salience, namely the dysfunctional attribution of value and salience to 
environmental stimuli underlies the pathophysiology of the illness (Kapur, 2003; Ziauddeen 
and Murray, 2010). The attraction of this framework is twofold. Firstly, it conceptualizes the 
saliency deficits connected with the pathology in terms of current psychological theories of 
motivation and value attribution (Berridge and Robinson, 1998). Secondly, given the well-
documented link between value processing and dopamine (Schultz, 2010), it connects 
established molecular dopaminergic disturbances in schizophrenia to their functional role in 
reward and incentive salience thereby providing a bridge between the phenomenology and 
neurobiology of the disorder. 
Incentive salience attribution involves assigning value to stimuli and depends on two 
interrelated aspects: how value is learnt and how it subsequently guides decision-making and 
behaviour. The former has been object of extensive investigation with evidence showing 
impaired reinforcement learning in schizophrenia. In particular, patients exhibited aberrant 
learning of cue-reward contingencies (e.g., Waltz and Gold, 2007; Gradin et al., 2011) and 
improper prediction-error processing (e.g., Waltz et al., 2011; Morris et al., 2012), namely 
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the mismatch between expected and actual rewards that drives learning. Furthermore, studies 
showed that such dysfunctions are correlated with neural disturbances in regions with 
prominent dopaminergic innervation, including the ventral striatum and the substantia 
nigra/ventral tegmental area (e.g., Murray et al., 2008; Nielsen et al., 2012; Schlagenhauf et 
al., 2009), providing support for the hypothesised link between aberrant incentive salience 
and dopaminergic unbalance. 
However, salience attribution also involves how values are used to guide decision-making 
independently of how these values are learnt. Previous studies have focused on learning (e.g., 
Averbeck et al., 2011), and do not dissociate this from value attribution, consisting in how 
much value is assigned to the different rewards. Hence the impact of value attribution 
independent of learning in schizophrenia is still poorly understood. Clarifying this is of 
particular importance so as to provide a proper quantification of the different facets of 
aberrant incentive salience in the disorder.  
To investigate value-based decision-making in schizophrenia, independently of learning, we 
used a monetary gambling task (Rigoli et al., 2016a; 2016b; 2016c; 2016d) in which 
participants were explicitly informed regarding the values associated with different options, 
thus not requiring any ongoing learning of such values. Note that previous studies on risky 
decision-making in schizophrenia focused prominently on the Iowa Gambling Task (IGT; 
Bechara et al., 1994) or the Balloon Analogue Risk Task (BART; Lejuez et al., 2003), which 
however involve learning of values. Here, we were able to differentiate between three distinct 
factors underlying value attribution in the task: (i) an individual baseline gambling preference 
independent of the values at stake; (ii) a gambling preference which is sensitive to the values 
of the available choice; (iii) a tendency to adapt preference attribution with respect to the 
contextual availability of rewards (Rigoli et al., 2016a). 
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In line with proposals of aberrant value processing in schizophrenia, we predicted that 
patients would show altered value processing even in the absence of learning demands. We 
thus predicted that patients would show reduced ability to tune their preference attribution 
both with respect to the current values at stake and to the contextual long-run availability of 
rewards. Furthermore, we predicted a likely association between such deficits and aberrant 
salience traits. 
 
2. Methods and Materials 
2.1. Participants 
Twenty volunteers with a diagnosis of schizophrenia based on the DSM-IV-TR (American 
Psychiatry Association, 2000; 18 males; mean age: 41.2) treated with atypical antipsychotic 
medication and twenty-two healthy controls (19 males; mean age: 40.5) were recruited via 
local community referrals and advertisement. Individuals were excluded if they had 
substance abuse within the last 6 months, any significant neurological, physical or learning 
disability. Controls had no personal or family history of mental illness. All volunteers 
underwent cognitive assessment; working memory (Digit Span; Wechsler, 1981) and the 
vocabulary and matrix reasoning scales of the Wechsler Abbreviated Scale of Intelligence 
(WASI; Wechsler, 1999). Patients’ symptoms severity was assessed using the Positive and 
Negative Syndrome Scale (PANSS; Kay et al., 1988). Aberrant salience traits were measured 
using the Aberrant Salience Inventory (Cicero et al., 2010). The study was approved by an 
appropriate ethical committee, and informed consent was obtained from all participants. 
 
2.2. Risk Task 
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The task (Figure 1), adapted from Rigoli and colleagues (Rigoli et al., 2016a), was 
programmed using Cogent 2000, developed by the Cogent 2000 team at the FIL and ICN. 
The task comprised of 480 trials; each trial consisted of participants selecting between two 
monetary options: a fixed amount (i.e., safe option) and a gamble where the potential 
outcomes were either zero or double the fixed amount. Therefore, both options had equal 
average expected amount. Participants completed 2 blocks of 240 trials lasting 40 minutes in 
total; each block was interleaved by 3 breaks to allow for rest. In each block, the amount of 
the safe option was randomly drawn from a uniform distribution with increments of £0.10. 
Crucially, the two blocks had a different monetary range: £1-£5 for the safe option in the 
low-value context and £2-£6 for the safe option in the high-value context. Note that the range 
difference across the two blocks was minimal to enhance area of overlap and thus statistical 
power (analyses performed on overlapping amounts). At the start of each block, a panel 
reminded subjects of the upcoming monetary range. Block order was counterbalanced across 
all subjects. After a fixed inter-trial interval of 1.5 seconds, each monetary option was 
displayed on a different side of a 15 inches computer screen. Participants were requested to 
choose between the left and right option by pressing the corresponding arrow key. After the 
choice was made, only the selected option remained on the screen for 500 milliseconds. Next, 
the gained outcome was displayed in the centre of the screen for 1 second. Participants had 3 
seconds to give their response; otherwise the words “too late” appeared and they got an 
outcome of zero. Gamble outcomes and positions of safe and gamble options were 
pseudorandomised. Before the experiment, all participants were given detailed instructions of 
task and their understanding was assessed. At the end of the task, one outcome was randomly 
selected and participants were paid accordingly. 
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3. Results 
3.1. Task Analysis 
Task analyses were conducted using the Statistical Package for the Social Sciences Version 
21.0 (SPSS 21.0) and MATLAB (2013a). A two-tailed significance level of α = 0.05 was 
adopted for all analyses. Demographic and clinical characteristics are shown in Table 1; 
significant group differences were found for WASI, Digit Span and Aberrant Salience 
Inventory. 
On average, participants gambled less than 50% of the time (mean = 40.08; SD = 22.85; t(41) 
= -2.81, p < 0.01) with no evidence for group differences (t(40) = -0.04, p = 0.97), suggesting 
that both groups were mildly risk-averse. There was no difference in gambling propensity 
across the two different value range blocks (t(41) = 0.85, p = 0.4) and such difference did not 
vary across groups (t(40) = -1.33, p = 0.19). 
Note that a single variable alone varied across trials, namely the trial average monetary 
amount. Indeed, the amount associated with the certain option was equal to the average 
amount of the gamble, given that the gamble had a 50/50 probability of obtaining zero or 
double the certain amount. We estimated the influence of the magnitude of trial monetary 
amount (i.e., predictor) on risky choice using logistic regression (i.e., dummy coding of 0 for 
certain option and 1 for gamble). Beta weights associated with the trial monetary amount 
indicated individuals’ preference to gamble with high or low amounts, a tendency we refer to 
as gambling slope. This was not significantly different from zero across participants (t(41) = - 
0.10, p = 0.92) and was not significantly different across groups (t(40) = -0.2, p = 0.84). 
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We next computed the absolute value of the gambling slope (here referred to as value-
sensitivity), indicating the impact of the trial amount on choice, independent of a preference 
to gamble with small or large amounts. This quantity captures to the how much preferences 
are flexibly tuned to the value on offer, an aspect we predicted to be impaired in 
schizophrenia. In line with predictions, patients were significantly less influenced by reward 
amounts as they showed a smaller value-sensitivity index (Figure 2; t(40) = 2.93, p < 0.01). 
In line with previous findings (Rigoli et al., 2016a; 2016b; 2016c; 2016d), a contextual 
influence was estimated by computing the difference in gambling percentage between low-
and high-value contexts for overlapping amounts (i.e., in the £2-£5 range), multiplied by the 
gambling slope. Positive values for this index capture a propensity for subjects who preferred 
to gamble with large amounts (i.e., having a positive gambling slope) to gamble more when 
the same amounts were relatively larger (i.e., in the low-value context), whereas participants 
who preferred to gamble with small amounts (i.e., having a negative gambling slope) also to 
gamble more when the same amounts were relatively smaller (i.e., in the high-value context). 
Overall, participants demonstrated evidence of such a corrected context effect (t(41) = 2.28, p 
= 0.03), but contrary to expectations no group differences were found (Figure 3; t(40) = 1.52, 
p = 0.14), suggesting that patients could make use of long-run reward context to assign value 
to monetary stimuli. Considering SCZ patients, no correlations were found between value 
sensitivity and symptoms severity (PANSS negative scale: r(20) = 0.20, p = 0.39; PANSS 
positive scale: r(20) = -0.22, p = 0.36) or medication dosage (r(20) = 0.08, p = 0.75).  
Overall these results indicate that patients show no difference from controls in the different 
dimensions of risky decision-making that we measured, except for value-sensitivity, which 
indicated that patients had an inability to tune their choice preference to reward amounts 
available on a trial. 
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3.2. Model-based Analysis 
We adopted a computational modelling approach to further investigate the differences 
between groups reported before. We implemented the same computational model as in a 
previous study (Rigoli et al., 2016) to characterize the computational mechanisms underlying 
choice behaviour. The model takes the form of a standard mean-variance return account for 
which the value of an option x corresponds to  ( )      ( )            ( ) . This 
model has three parameters: τ, which implements a (subtractive) normalization of the trial 
amount associated with the high-value context; α, which determines whether reward variance 
(i.e., risk) is attractive (α > 0) or not (α < 0), and which reflects the tendency to gamble 
dependent on the trial amount; and μ, which determines a baseline propensity to gamble. 
Taking A as the trial monetary amount (i.e., the certain reward) and χ as an indicator of the 
low-value (χ = 0) or high-value context (χ = 1), then the value of gambling is         
    (    )   , the value of the certain option is           , with the probability 
of choosing the gamble given by a sigmoidal choice rule  (           )    (  
   (            )) . Using the Bayesian Information Criterion (BIC) scores, we 
compared this model with simpler versions where one or two parameters were fixed. For both 
schizophrenia (SCZ) and healthy controls (HC), the full model had a lower BIC (HC: 
9760.08; SCZ: 11113.79) than those with gambling slope only (HC: 10903.14; SCZ: 
11466.31), average gambling percentage only (HC: 10970.86; SCZ: 11259.97), or the last 
two parameters together (HC: 9936.22; SCZ: 11165.57), suggesting that all three factors 
influence participants’ behaviour. Based on this model, parameters of the winning model 
correlated with behavioural measures such that the average gambling percentage correlated 
with the baseline gambling coefficient μ (r(42) = 0.57, p < 0.01), the gambling slope 
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correlated with the value function coefficient α (r(42) = 0.8, p < 0.01) and the context 
coefficient τ correlated with the corrected context effect (ρ(32) = 0.33, p = 0.03). No 
significant group differences were found for the model parameters (μ: t(40) = -0.46, p = 0.65; 
α: t(40) = -0.77, p = 0.45; τ: t(40) = 0.02, p = 0.98). However, the absolute value of the 
coefficient α was significantly larger in HC compared to SCZ (t(40) = 2.29, p = 0.03). This is 
consistent with the results reported above given that the parameter α is tightly connected with 
the gambling slope. 
 
 
To investigate the influence of previous trial outcome on participants’ decision-making, we 
estimated a logistic regression model of choice including as predictor a dummy regressor 
whose values were set to one for wins and to zero otherwise. We found no group difference 
on the estimated betas (t(40) = 3.36; p = 0.4), suggesting that patients did not show any 
difference in this regard. To explore the influence on choice of expected value at preceding 
trial, we estimated a logistic regression with the expected value at the preceding trail as 
predictor. We found no group differences on the estimated betas (t(40) = 0.4, p = 0.69). 
Overall, the model-based analysis confirms that controls and schizophrenia patients differ 
with regards to the strength of the influence of the trial monetary amount (here associated 
with the absolute value of the parameter α on choice), while all other aspects of choice 
mechanism did not differ. 
 
3.3. Relationship with aberrant salience and cognitive measures 
One of our main goals was to investigate the connection between the concept of aberrant 
salience and value attribution during decision-making under risk. Consistent with a link 
between these two domains, value-sensitivity was inversely correlated with the scoring on the 
Aberrant Salience Inventory (Figure 4A; r(37) = -0.36, p = 0.03). To test for non-linearity in this 
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relationship, we performed a one-way ANOVA on the trait aberrant salience measure with the 
quartiles of the value-sensitivity index as factor. This implies that participants (we considered 
only those who filled the ASI, n = 37) were ordered according to their value-sensitivity index and 
were grouped in four bins (bin one, two and three included 9 participants; bin four included 10 
participants). We observed a difference in the aberrant salience levels across the quartile bins 
(Figure 4B; F(3,33) = 3.46, p = 0.03), a result driven by a larger aberrant salience score for the 
first quartile bin compared to the others (first vs second bin: t(16) = 2.98, p < 0.01; first vs third: 
t(16) = 2.71, p = 0.02; first vs fourth: t(17) = 2.96, p < 0.01; second vs third bin: t(16) = -0.28, 
p = 0.78; third vs fourth bin: t(17) = 0.36, p = 0.73). As both value-sensitivity and the 
aberrant salience score were significantly different across groups, we ran a mediation 
analysis using logistic regression with group as the dependent variable and value-sensitivity 
and the aberrant salience score as predictors. We found the beta weight associated with the 
aberrant salience score was not significant (B = 0.09; SE = 0.06; p = 0.12) while the beta 
weight associated with value-sensitivity was (B = -0.07; SE = 0.03; p = 0.04). This indicates 
that the relationship between group and aberrant salience was mediated by value-sensitivity. 
We further observed that value-sensitivity (but not the Aberrant Salience Inventory) 
correlated with both IQ (Figure 4C; WASI; r(42) = 0.29, p = 0.06, trend) and working 
memory (Figure 4D; Digit Span; r(38) = 0.41, p = 0.01). As all these measures varied across 
groups (see Table 1), we investigated the contribution of the value-sensitivity index relative 
to the other measures in differentiating between patients and controls. We thus ran a 
mediation analysis using logistic regression with group as the dependent variable and value-
sensitivity, IQ and working memory score as predictors. We found the beta weights 
associated with IQ (B = -0.04; SE = 0.02; p = 0.12) and working memory (B = -0.11; SE = 
0.1; p = 0.26) were not significant, while the beta weight associated with value-sensitivity 
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was (B = -0.07; SE = 0.03; p = 0.03). This indicates that the relationship between group and 
cognitive measures was mediated by value-sensitivity. 
Overall, these results indicate that value-sensitivity best discriminated patients from controls 
since it mediated the impact of aberrant salience score, working memory and IQ on group. 
 
4. Discussion 
Neurocognitive models of pathophysiology in schizophrenia emphasize the role of aberrant 
incentive salience in the illness. This framework has been fruitful in linking dopaminergic 
disturbance in schizophrenia to motivational and decision-making impairments in value-
based learning. However, the mechanisms underlying improper value attribution independent 
of learning deficits in schizophrenia are still poorly understood. This is important because 
various facets of value processing need to be investigated in order to provide a composite 
understanding of when and how aberrant salience is impaired in schizophrenia; especially as 
the framework fails to delineate the cognitive mechanisms underpinning value misattribution. 
Thus, we here investigated the mechanisms underlying value attribution free from learning 
by comparing the performance of schizophrenia patients and healthy control participants in a 
gamble task requiring repeated expressions of preference in the absence of learning. 
Importantly, our task enabled us to measure several components of value attribution under 
risk (i.e., a gambling tendency independent of the amounts at stake, a gambling preference 
dependent on the available amounts, a tendency to adapt decision-making to the different 
contextual availability of rewards) and thus to disentangle the specific mechanisms 
underlying aberrant incentive salience in the illness. 
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Patients demonstrated less influence of reward amount on their choices compared to healthy 
participants. The apparent insensitivity to this information reflects patients’ inability to tune 
value attribution and concurrent decision-making to the variation of rewards in their 
environment. This finding may help clarifying significant impairments exhibited by patients 
in everyday life. Insensitivity to values and the inability to tune choices to those values may 
indeed account for several motivational aberrances, such as the inability to weight the risks 
associated with maladaptive behaviours, resulting in lack of medical compliance 
(Rettenbacher et al., 2004) and impulsive behaviour (Ouzir, 2013), or to engage in properly 
motivated behaviour (Strauss et al., 2014). In addition, a reduced sensitivity to value clarifies 
the mechanisms of aberrant incentive salience in schizophrenia, proposed as a key drive of 
both negative (Zauddeen and Murray, 2010) and positive (Kapur, 2003) symptoms. First, 
insensitivity to value can be potentially implicated in negative symptoms, as it might well 
result in reduced motivational drive with rewards and punishments. Second, reduced value 
sensitivity may play a role in the genesis of positive symptoms too, which according to the 
aberrant salience hypothesis arise from an attempt to cope with aberrant incentive salience 
(of which value sensitivity is a key aspect). Here, we found no association between value 
sensitivity and symptoms; however this may be due to our sample lacking sufficient variation 
on PANSS scores – future studies could explore this association further by performing 
stratified sampling. 
We note that few studies investigated risky decision-making without learning in the context 
of schizophrenia. Heerey and colleagues (2008) asked participants to choose between two 
gambles differing for reward amounts, associated probabilities and potential outcomes (i.e., 
win, lose or nothing). They fitted a logistic regression model estimating the probability of 
choosing the more extreme gamble on the basis of outcome (wins or losses) and probability 
and reported reduced beta coefficients to losses in the patients compared to controls; however 
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as no tests on absolute betas were reported, it is not clear if this reflects increased tendency to 
gamble with low amounts (and probabilities) or reduced influence of losses on patients’ 
decision-making. In a more recent study (Brown et al., 2013) subjects were asked to choose 
to either take, or not, a gamble with equal probability of either winning or losing an amount 
which could exceed, be less or equal than the amount of the concurrent potential outcome. In 
line with our results, patients showed reduced influence of the magnitude of their gains and 
losses on their behaviour. However, in this task, the participants were required to weigh the 
magnitude of differential gains and losses against each other. The ability to perform such 
mathematical comparisons relies heavily on executive functions and indeed authors report 
correlations between their task and both IQ and working-memory measures. On the contrary, 
our task avoids such complicated comparisons by only manipulating the gain amount set 
against the zero. As such, we could show that the absolute value of the gambling slope 
correlated with both cognitive (i.e., working memory and IQ) and motivational (i.e., aberrant 
salience) functions. 
One of our main predictions was that dysfunctional value attribution during decision-making 
would be linked to aberrant salience experiences in the disorder. In support of this we found 
an inverse correlation between subjects’ ability to tune to reward amounts’ (i.e., our value-
sensitivity index) and a measure of trait aberrant salience (i.e., Aberrant Salience Inventory). 
To our knowledge, this is the first report linking task behaviour to trait aberrant salience. The 
relevance of this finding is twofold. First, it connects an inability to take into account 
stimulus value to an expression of aberrant salience. Second, it further clarifies the nature of 
such construct by providing a specific and quantitative description of underlying 
computational mechanisms. To further investigate the relevance to the illness of such two 
indexes, we asked whether value-sensitivity index or the Aberrant Salience Inventory best 
differentiated between the two groups. Results revealed that while value-sensitivity fully 
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mediated the relation between group and trait aberrant salience, the latter did not mediate the 
relation between group and value-sensitivity. This suggests that our index might be a better 
predictor of illness compared to existent self-reports measures of aberrant salience. 
An interesting aspect pertains to the role of intellectual level in motivational and value-based 
processing (Collins et al., 2012). In this regard, we found a correlation between value-
sensitivity and measures of IQ (i.e., WASI) and working-memory (i.e., Digit Span). As the 
between-group differences were found for all these indexes, we first investigated whether 
these intellectual abilities could explain group differences on our value-sensitivity index, but 
this was not the case. We then found value-sensitivity to mediate the relation between 
cognitive measures and group. These findings suggest that the value-sensitivity index, 
namely subjects’ ability to tune to reward amounts in our task, discriminated patients from 
controls better than the standard cognitive measures. In sum, value-sensitivity was a better 
predictor of whether a subject belonged to the patient or control group than aberrant salience, 
working memory and IQ. This might be explained by the fact that, the value-sensitivity index 
reflects both intellectual as well as motivational mechanisms, whereas aberrant salience taps 
into motivational mechanisms alone and working memory and IQ into intellectual 
mechanisms only. Contrary to our predictions, patients exhibited preserved ability to 
normalise values depending on the long run reward context. This was unexpected as patients 
have demonstrated contextual impairments in various domains, including perception (Robol 
et al., 2013) and socio-cognition (Fett et al., 2012). However, direct comparisons are difficult 
as these studies varied greatly in types of tasks used and domains investigated. One study 
investigated contextual effects in reward processing in the illness (Brown et al., 2013). This 
study employed a gambling task where participants could either gamble to achieve a greater 
gain, relative to a certain smaller one, or gamble to avoid a certain loss but with the risk of 
incurring a larger loss. As the expected values across the two trial types were identical, the 
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basis of the individuals’ preference reflected the influence of the framing effect in the way 
the options were presented (Kahneman and Tversky, 1979; De Martino et al., 2006). Unlike 
healthy individuals, schizophrenia patients did not exhibit such framing effects. The 
discrepancy between this and our finding of absence of contextual deficits in patients might 
be attributable to the differential time-frame of the contextual adaptation required. Indeed, 
whereas in Brown and colleagues’ study (2013) context was changing rapidly, our task 
allowed for a long-run adaptation to occur; thus suggesting that patients are able to 
incorporate contextual information if they have sufficient time to do so. 
We observed no relationship between value sensitivity and medication dosage in patients, 
implying that it is unlikely that a lower value sensitivity observed in patients was a 
consequence of medication. This suggests that value sensitivity is unaffected by 
dopaminergic drugs, also in line with a recent study manipulating levodopa (a dopamine 
agonist) and adopting a task similar to the one employed here (Rigoli et al., 2016b). Hence, 
whether dopamine plays any role in value sensitivity (as one may predict based on the 
aberrant salience hypothesis) remains unclear, and available evidence suggests it does not. 
This leaves open the question on the neural determinants of value sensitivity. 
There were no differences between the groups in the preference to gamble more with high or 
low amounts. This speaks against the possibility that schizophrenia patients, as a whole, are 
simply overly drawn to salient stimuli, in this case represented by larger monetary amounts. 
Furthermore, we also found no group differences for the baseline tendency to gamble. This 
contrasts with reports of gambling tendencies in patients (Potenza et al., 2001) and it suggests 
that more complex mechanisms of aberrant value attribution might underlie such gambling 
issues in patients. Our study has some limitations. First, it is possible that antipsychotic 
medication might account for some of the results on the behavioural task. However, the lack 
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of a correlation between performance and medication dosage suggests this is unlikely. 
Second, we found no correlation between symptoms and task performance; this might be due 
to an insufficient range of symptoms in our sample. Future studies should clarify the link 
between observed motivational dysfunctions and symptoms. Third, our task involved small 
monetary amounts and reward contexts with similar reward distributions. It remains to be 
clarified whether, when reward amounts are larger and contextual differences are greater, 
contextual effects and gambling propensities similar to those observed here emerge. 
In conclusion we find that in keeping with a proposal of dysfunctional value attribution in 
schizophrenia, we observed a reduction in patients’ ability to tune value attribution and 
concurrent decision-making to the reward magnitudes. This might underlie difficulties in 
making optimal choices in real life. Crucially, abnormal insensitivity to values in our task 
was linked to aberrant salience traits, suggesting that such mechanism might form the basis 
of aberrant salience attributions experienced daily in the disorder. The present study 
permitted analysis of several key components of choice behaviour, free from learning 
confounds; something necessary to better delineate the mechanisms underlying aberrant 
salience in the illness. 
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Table and Legends 
Table 1. Demographic and clinical characteristics 
 
Figure 1. Experimental Paradigm 
 
Figure 2. Group differences in value sensitivity 
 
 
Figure 3. Depiction of gambling percentages for each monetary bin (i.e., bin1 = £1-£2, bin2 = £2-
£3, bin3 = £3-£4, bin4 = £4-£5 in the low value context and bin1 = £2-£3, bin2 = £3-£4, bin3 = £4-
£5, bin4 = £5-£6 in the high value context) separately for gambling slope (i.e., positive and 
negative) and group. Red arrows connect bins with equal monetary amount and highlight the 
presence of context effect. 
 
Figure 4. Depiction of relationship between value sensitivity and (A) aberrant salience (ASI), (C) 
IQ (WASI) and (D) working memory (Digit Span). HC and SCZ are represented by triangles and 
circles respectively. Figure (B) shows that the relationship between value sensitivity and aberrant 
salience is driven by those with higher aberrant salience scores. 
 
 
 
Demographic and clinical characteristics SCZ (n = 20) HC (n = 22) Test statistic P value 
Age: mean (SD) 41.2 (1.64) 40.5 (1.69) t (40) = -0.3 0.77 
Gender/male: n (%) 18 (90) 19 (86.36) FET 1 
Handedness/right: n (%) 19 (95.45) 21 (95.45) FET 1 
WASI: mean (SD) 99.75 (15.49) 110.32 (14.75) t (40) = 2.26 0.03 
Digit Span: mean (SD)
a 
15.82 (3.58) 18.38 (3.93) t (36) = 2.08 0.05 
Aberrant Salience Inventory (SD)b 15.73 (5.99) 10.36 (6.9)   t(35) = -2.45 0.02 
PANSS Positive: mean (SD) 18.75 (4.91) -- -- -- 
PANSS Negative: mean (SD) 20.45 (4.15) -- -- -- 
PANSS General: mean (SD) 37.05 (8.41) -- -- -- 
Medication: mean (SD)
c 
561.65 (420.07) -- -- --  
SCZ: volunteers diagnosed with schizophrenia, HC: healthy controls, SD: standard deviation, WASI: Wechsler 
Abbreviated Scale of Intelligence, PANSS: Positive and Negative Syndrome Scale, FET: Fisher’s Exact Test. 
a Digit Span is missing in 3 SCZ and 1 HC.
 
b Chlorpromazine equivalent (mg per day).
 
c ASI is missing in 5 SCZ. 
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Highlights 
 
 
1. Pathophysiology in schizophrenia has been linked to aberrant value processing, but 
how value is used to guide behaviour in schizophrenia is unknown. 
2. In the context of value guiding decision-making, we found reduced value sensitivity 
in patients with schizophrenia 
3. Reduced value sensitivity was linked with aberrant experiences of value processing 
affecting patients in daily life 
4. Our results clarify value processing deficits in schizophrenia and may thus inform 
cognitive interventions aimed at reinstating value sensitivity in patients. 
 
 
